What is Teva Pharmaceutical Industries Ltd worth?
With the base-case assumptions below, a discounted cash flow model on Teva Pharmaceutical Industries Ltd's reported free cash flow gives $13.10 per share. The share price was $38.88 on September 28, 2026, 197% above that value.
Inputs from the filings
Three sets of assumptions
| Case | Growth yrs 1-5 | Discount rate | Value per share | Value vs price |
|---|---|---|---|---|
| Bear | -4.5% | 10.0% | $7.91 | -80% |
| Base | 0.5% | 9.0% | $13.10 | -66% |
| Bull | 5.5% | 8.0% | $23.20 | -40% |
Sensitivity: base case value per share
| 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | |
|---|---|---|---|---|---|
| 7.0% | $16.70 | $17.77 | $19.09 | $20.74 | $22.86 |
| 8.0% | $14.03 | $14.73 | $15.55 | $16.54 | $17.76 |
| 9.0% | $12.07 | $12.55 | $13.10 | $13.74 | $14.50 |
| 10.0% | $10.57 | $10.91 | $11.30 | $11.74 | $12.25 |
| 11.0% | $9.39 | $9.64 | $9.92 | $10.23 | $10.59 |
Where the presets come from
Base: years 1 to 5 grow at Teva Pharmaceutical Industries Ltd's revenue growth rate over the last 5 fiscal years (0.7% a year), held between -5% and 15%. Years 6 to 10 grow halfway between that and the long-run rate of 2.5%. Future cash is discounted at 9% a year.
Bear: 5 points less growth, 2% long-run growth, 10% discount rate. Bull: 5 points more growth (at most 25%), 3% long-run growth, 8% discount rate.
Value per share = (present value of 10 years of free cash flow + present value of everything after + cash - debt) / diluted shares.
This is a model run on assumptions, not a recommendation or a price target. Small changes in the discount rate or growth move the result a lot, as the table above shows. Change them yourself in the calculator.
Adjust the assumptions
Move the sliders for growth, long-run growth and discount rate, or switch to average free cash flow, and see the value per share change.
Adjust the assumptions